Gland Pharma has named Ajay Sahni as the new CEO of its Singapore subsidiary, Gland Singapore, effective November 2, 2026.

Sanofi is set to pursue larger acquisitions and enhance its growth strategy under the leadership of CEO Belen Garijo, aiming ...

Senores Pharmaceuticals has announced its Q2 FY27 financial results, showcasing a 25% increase in revenue to ₹192 crore, ...

Wockhardt reports a 24% increase in Q2 revenue, reaching ₹939 crore, but net profit drops as the company invests heavily in ...

India's pharmaceutical industry has experienced unprecedented double-digit growth over the past four quarters, driven mainly by chronic care drug sales. Expectations of sustainable growth continue as ...

Granules India receives a form 483 from the FDA with 11 observations during inspection, highlighting process and documentation improvements needed at their Gagillapur facility. No data integrity or ...

Laurus Labs expands its capabilities in the oligonucleotide and peptide sectors with strategic acquisitions, enhancing R&D, ...

Fresenius has entered a major development agreement with WuXi Biologics to enhance its biosimilars pipeline, targeting a ...

AstraZeneca reveals a strategic plan to save $1.5 billion annually for investment in its drug pipeline, signaling a ...

A Delhi court discharges former Joint Drugs Controller Dr. S. Eswara Reddy and three others in a bribery case involving ...

Sun Pharmaceutical Industries has received regulatory approval to manufacture and market its generic semaglutide pill in ...

Gilead Sciences increases its 2026 sales outlook to $31-$31.3 billion while announcing a 38% price reduction for Biktarvy ...